Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (1842)	2/25/1999 1:24:00 PM
From: billy d	Read Replies (1) \| Respond to of 10280

Peter, You are right about having a skeptic on board. Nothing like a dose of reality to keep me in line. Wolfdog, I apologize if I came off the wrong way on my post. IMO you have posted tastefully and your input is welcome by me. The point I was trying to make is I don't fully understand why people post on boards of stocks where they have no investment, in be it long or short. The only reason I can see for it is to try to get answers if they are thinking about taking a position. Just my thoughts on this tough day if your a bull and good luck to all.

To: Biomaven who wrote (1842)	2/25/1999 7:06:00 PM
From: j_fir2	Read Replies (4) \| Respond to of 10280

Other companies are beginning to patent the ICE of their own compounds, going forward. They have seen SEPR's strategy and find they can adopt it themselves. Perhaps that was what the Forbes guy was talking about. I wonder-still, as a fairly ardent and pleased long, and mostly privately--about the value some of the ICEs will have when they are on the market. I think people are hoping that Prozac II will be a new drug. It won't. Neither is Allegra a superb Seldane, as far as I can tell. Useful, yes. I wonder how sales are doing, actually. I am eager to see what SEPR comes up with for NCEs. For a biotech, they have a really cool cash-flow plan to support their original research! In the meantime, what I have seen of SEPR is that it is a hugely aggressive company, with scads of aggressive scientists and lawyers. Sure, I'll invest here. ('Specially since I've seen the shares go from 25 to 120 in a year and a half.) Of course Southwell sounds good when he's interviewed! How else could he be the CEO of this particular company?